ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 638199 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 638199; 2) Community: the network communities that were significantly associated with the response to NSC 638199; 3) Molecule: the relationships between components within communities and NSC 638199; 4) MDR: the compounds that were significantly associated with the NSC 638199.

NSC Compound Enrichment Correlation
NSC 67586 2-Naphthacenecarboxamide, N-[[(6,7-dihydro-7-oxo-1H-1,2,3-triazolo[4,5-d]pyrimidin-5-yl)amino]methyl]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, 0.00356914129105577 0.3277015
NSC 677696 Benzoic acid, 4-[[(2,5-dihydroxyphenyl)methyl]amino]- tert-butyl ester 0.00356914129105577 0.4769915
NSC 684496 Benzoic acid, 4-[2-(3,6-dioxo-1,4-cyclohexadienyl)ethyl]-, isopropyl ester 0.00356914129105577 0.63050777
NSC 700455 Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- 0.00356914129105577 0.53641485
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.00356914129105577 0.58119979
NSC 716951 Null 0.00356914129105577 0.38709829
NSC 720447 Null 0.00356914129105577 -0.3884675
NSC 721049 7Z-Plakortide H 0.00356914129105577 0.35901322
NSC 740 Methotrexate 0.00356914129105577 0.49014763
NSC 671031 Null 0.00385572727186002 0.34146917
Total:109  Current:14    [First] [Prev] [Next] [Last]